Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colitis, Ulcerative | 1 | 2024 | 208 | 0.760 |
Why?
|
| Intestinal Fistula | 1 | 2021 | 28 | 0.760 |
Why?
|
| Skin Ulcer | 1 | 2021 | 33 | 0.760 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2024 | 504 | 0.690 |
Why?
|
| Biological Products | 1 | 2021 | 121 | 0.630 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2021 | 224 | 0.620 |
Why?
|
| Crohn Disease | 1 | 2021 | 284 | 0.610 |
Why?
|
| Virtual Reality | 1 | 2018 | 27 | 0.600 |
Why?
|
| Preceptorship | 1 | 2018 | 33 | 0.590 |
Why?
|
| Manikins | 1 | 2018 | 135 | 0.560 |
Why?
|
| Proton Pump Inhibitors | 1 | 2019 | 259 | 0.550 |
Why?
|
| Teaching | 1 | 2018 | 189 | 0.540 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2018 | 241 | 0.530 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2017 | 313 | 0.510 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2016 | 65 | 0.510 |
Why?
|
| Cost of Illness | 1 | 2017 | 248 | 0.490 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2016 | 243 | 0.470 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 606 | 0.450 |
Why?
|
| Liver Cirrhosis | 2 | 2016 | 832 | 0.410 |
Why?
|
| Caregivers | 1 | 2017 | 582 | 0.380 |
Why?
|
| Colonoscopy | 3 | 2015 | 234 | 0.290 |
Why?
|
| Colonic Polyps | 2 | 2015 | 78 | 0.210 |
Why?
|
| Adenoma | 2 | 2015 | 131 | 0.210 |
Why?
|
| Precancerous Conditions | 2 | 2015 | 283 | 0.190 |
Why?
|
| Biological Factors | 1 | 2021 | 27 | 0.180 |
Why?
|
| Infliximab | 1 | 2021 | 67 | 0.180 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2020 | 75 | 0.170 |
Why?
|
| Barrett Esophagus | 1 | 2024 | 339 | 0.160 |
Why?
|
| Esophageal Neoplasms | 1 | 2024 | 361 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 1110 | 0.160 |
Why?
|
| Drug Monitoring | 1 | 2021 | 170 | 0.160 |
Why?
|
| Colorectal Neoplasms | 2 | 2015 | 563 | 0.150 |
Why?
|
| Severity of Illness Index | 2 | 2024 | 2906 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 682 | 0.150 |
Why?
|
| Humans | 13 | 2024 | 124905 | 0.140 |
Why?
|
| Nadolol | 1 | 2016 | 28 | 0.130 |
Why?
|
| Interferon-gamma Release Tests | 1 | 2017 | 82 | 0.130 |
Why?
|
| Ascites | 1 | 2016 | 88 | 0.130 |
Why?
|
| Propranolol | 1 | 2016 | 128 | 0.130 |
Why?
|
| Proportional Hazards Models | 2 | 2016 | 1352 | 0.130 |
Why?
|
| Primary Prevention | 1 | 2016 | 170 | 0.120 |
Why?
|
| Mortality | 1 | 2016 | 237 | 0.120 |
Why?
|
| Comorbidity | 2 | 2016 | 1533 | 0.120 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 404 | 0.110 |
Why?
|
| Proctoscopy | 1 | 2013 | 6 | 0.110 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2017 | 378 | 0.110 |
Why?
|
| Heart Rate | 1 | 2016 | 595 | 0.110 |
Why?
|
| Diagnostic Errors | 1 | 2017 | 333 | 0.110 |
Why?
|
| Intestinal Polyps | 1 | 2013 | 29 | 0.110 |
Why?
|
| Adenomatous Polyps | 1 | 2013 | 13 | 0.110 |
Why?
|
| Age Factors | 2 | 2016 | 2821 | 0.100 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2017 | 422 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1692 | 0.100 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2016 | 666 | 0.100 |
Why?
|
| Rectal Neoplasms | 1 | 2013 | 79 | 0.100 |
Why?
|
| Hepatitis C, Chronic | 1 | 2016 | 324 | 0.100 |
Why?
|
| Stress, Psychological | 1 | 2017 | 557 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 936 | 0.090 |
Why?
|
| Tuberculosis | 1 | 2017 | 519 | 0.090 |
Why?
|
| Colonic Neoplasms | 1 | 2013 | 249 | 0.090 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 1318 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2024 | 12354 | 0.080 |
Why?
|
| Cohort Studies | 1 | 2016 | 4788 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2016 | 3439 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2017 | 2043 | 0.070 |
Why?
|
| Middle Aged | 4 | 2017 | 26756 | 0.060 |
Why?
|
| United States | 2 | 2016 | 10884 | 0.060 |
Why?
|
| Optical Fibers | 1 | 2024 | 18 | 0.060 |
Why?
|
| Risk Factors | 1 | 2016 | 10281 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2024 | 582 | 0.050 |
Why?
|
| Aged | 2 | 2016 | 19712 | 0.050 |
Why?
|
| Cholagogues and Choleretics | 1 | 2020 | 25 | 0.040 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2020 | 37 | 0.040 |
Why?
|
| Adult | 2 | 2017 | 29498 | 0.040 |
Why?
|
| Male | 4 | 2017 | 61355 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2016 | 16309 | 0.040 |
Why?
|
| Female | 3 | 2017 | 66624 | 0.030 |
Why?
|
| Health Status | 1 | 2016 | 374 | 0.030 |
Why?
|
| Cause of Death | 1 | 2016 | 472 | 0.030 |
Why?
|
| End Stage Liver Disease | 1 | 2016 | 182 | 0.030 |
Why?
|
| Proctoscopes | 1 | 2013 | 2 | 0.030 |
Why?
|
| Colonoscopes | 1 | 2013 | 10 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 344 | 0.030 |
Why?
|
| Fiber Optic Technology | 1 | 2013 | 46 | 0.030 |
Why?
|
| Comparative Effectiveness Research | 1 | 2013 | 68 | 0.030 |
Why?
|
| Microscopy | 1 | 2013 | 117 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2013 | 208 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 1425 | 0.030 |
Why?
|
| Rectum | 1 | 2013 | 99 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 1285 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2013 | 165 | 0.030 |
Why?
|
| Observer Variation | 1 | 2013 | 299 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 329 | 0.020 |
Why?
|
| Video Recording | 1 | 2013 | 183 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 356 | 0.020 |
Why?
|
| Survival Rate | 1 | 2016 | 2038 | 0.020 |
Why?
|
| Smoking | 1 | 2016 | 1044 | 0.020 |
Why?
|
| Colon | 1 | 2013 | 353 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2017 | 3290 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 769 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 598 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 872 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 2143 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 1895 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2013 | 780 | 0.020 |
Why?
|
| Hypertension | 1 | 2016 | 1317 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 6143 | 0.020 |
Why?
|
| Heart Failure | 1 | 2016 | 2308 | 0.010 |
Why?
|